Genetic Analysis of the Cardiac Methylome at Single Nucleotide Resolution in a Model of Human Cardiovascular Disease

Epigenetic marks such as cytosine methylation are important determinants of cellular and whole-body phenotypes. However, the extent of, and reasons for inter-individual differences in cytosine methylation, and their association with phenotypic variation are poorly characterised. Here we present the...

Full description

Bibliographic Details
Main Authors: Johnson, Michelle D., Mueller, Michael, Adamowicz-Brice, Martyna, Collins, Melissa J., Gellert, Pascal, Maratou, Klio, Srivastava, Prashant K., Rotival, Maxime, Butt, Shahena, Game, Laurence, Atanur, Santosh S., Silver, Nicholas, Norsworthy, Penny J., Langley, Sarah R., Petretto, Enrico, Pravenec, Michal, Aitman, Timothy J.
Format: Online
Language:English
Published: Public Library of Science 2014
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4256262/
id pubmed-4256262
recordtype oai_dc
spelling pubmed-42562622014-12-11 Genetic Analysis of the Cardiac Methylome at Single Nucleotide Resolution in a Model of Human Cardiovascular Disease Johnson, Michelle D. Mueller, Michael Adamowicz-Brice, Martyna Collins, Melissa J. Gellert, Pascal Maratou, Klio Srivastava, Prashant K. Rotival, Maxime Butt, Shahena Game, Laurence Atanur, Santosh S. Silver, Nicholas Norsworthy, Penny J. Langley, Sarah R. Petretto, Enrico Pravenec, Michal Aitman, Timothy J. Research Article Epigenetic marks such as cytosine methylation are important determinants of cellular and whole-body phenotypes. However, the extent of, and reasons for inter-individual differences in cytosine methylation, and their association with phenotypic variation are poorly characterised. Here we present the first genome-wide study of cytosine methylation at single-nucleotide resolution in an animal model of human disease. We used whole-genome bisulfite sequencing in the spontaneously hypertensive rat (SHR), a model of cardiovascular disease, and the Brown Norway (BN) control strain, to define the genetic architecture of cytosine methylation in the mammalian heart and to test for association between methylation and pathophysiological phenotypes. Analysis of 10.6 million CpG dinucleotides identified 77,088 CpGs that were differentially methylated between the strains. In F1 hybrids we found 38,152 CpGs showing allele-specific methylation and 145 regions with parent-of-origin effects on methylation. Cis-linkage explained almost 60% of inter-strain variation in methylation at a subset of loci tested for linkage in a panel of recombinant inbred (RI) strains. Methylation analysis in isolated cardiomyocytes showed that in the majority of cases methylation differences in cardiomyocytes and non-cardiomyocytes were strain-dependent, confirming a strong genetic component for cytosine methylation. We observed preferential nucleotide usage associated with increased and decreased methylation that is remarkably conserved across species, suggesting a common mechanism for germline control of inter-individual variation in CpG methylation. In the RI strain panel, we found significant correlation of CpG methylation and levels of serum chromogranin B (CgB), a proposed biomarker of heart failure, which is evidence for a link between germline DNA sequence variation, CpG methylation differences and pathophysiological phenotypes in the SHR strain. Together, these results will stimulate further investigation of the molecular basis of locally regulated variation in CpG methylation and provide a starting point for understanding the relationship between the genetic control of CpG methylation and disease phenotypes. Public Library of Science 2014-12-04 /pmc/articles/PMC4256262/ /pubmed/25474312 http://dx.doi.org/10.1371/journal.pgen.1004813 Text en © 2014 Johnson et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Johnson, Michelle D.
Mueller, Michael
Adamowicz-Brice, Martyna
Collins, Melissa J.
Gellert, Pascal
Maratou, Klio
Srivastava, Prashant K.
Rotival, Maxime
Butt, Shahena
Game, Laurence
Atanur, Santosh S.
Silver, Nicholas
Norsworthy, Penny J.
Langley, Sarah R.
Petretto, Enrico
Pravenec, Michal
Aitman, Timothy J.
spellingShingle Johnson, Michelle D.
Mueller, Michael
Adamowicz-Brice, Martyna
Collins, Melissa J.
Gellert, Pascal
Maratou, Klio
Srivastava, Prashant K.
Rotival, Maxime
Butt, Shahena
Game, Laurence
Atanur, Santosh S.
Silver, Nicholas
Norsworthy, Penny J.
Langley, Sarah R.
Petretto, Enrico
Pravenec, Michal
Aitman, Timothy J.
Genetic Analysis of the Cardiac Methylome at Single Nucleotide Resolution in a Model of Human Cardiovascular Disease
author_facet Johnson, Michelle D.
Mueller, Michael
Adamowicz-Brice, Martyna
Collins, Melissa J.
Gellert, Pascal
Maratou, Klio
Srivastava, Prashant K.
Rotival, Maxime
Butt, Shahena
Game, Laurence
Atanur, Santosh S.
Silver, Nicholas
Norsworthy, Penny J.
Langley, Sarah R.
Petretto, Enrico
Pravenec, Michal
Aitman, Timothy J.
author_sort Johnson, Michelle D.
title Genetic Analysis of the Cardiac Methylome at Single Nucleotide Resolution in a Model of Human Cardiovascular Disease
title_short Genetic Analysis of the Cardiac Methylome at Single Nucleotide Resolution in a Model of Human Cardiovascular Disease
title_full Genetic Analysis of the Cardiac Methylome at Single Nucleotide Resolution in a Model of Human Cardiovascular Disease
title_fullStr Genetic Analysis of the Cardiac Methylome at Single Nucleotide Resolution in a Model of Human Cardiovascular Disease
title_full_unstemmed Genetic Analysis of the Cardiac Methylome at Single Nucleotide Resolution in a Model of Human Cardiovascular Disease
title_sort genetic analysis of the cardiac methylome at single nucleotide resolution in a model of human cardiovascular disease
description Epigenetic marks such as cytosine methylation are important determinants of cellular and whole-body phenotypes. However, the extent of, and reasons for inter-individual differences in cytosine methylation, and their association with phenotypic variation are poorly characterised. Here we present the first genome-wide study of cytosine methylation at single-nucleotide resolution in an animal model of human disease. We used whole-genome bisulfite sequencing in the spontaneously hypertensive rat (SHR), a model of cardiovascular disease, and the Brown Norway (BN) control strain, to define the genetic architecture of cytosine methylation in the mammalian heart and to test for association between methylation and pathophysiological phenotypes. Analysis of 10.6 million CpG dinucleotides identified 77,088 CpGs that were differentially methylated between the strains. In F1 hybrids we found 38,152 CpGs showing allele-specific methylation and 145 regions with parent-of-origin effects on methylation. Cis-linkage explained almost 60% of inter-strain variation in methylation at a subset of loci tested for linkage in a panel of recombinant inbred (RI) strains. Methylation analysis in isolated cardiomyocytes showed that in the majority of cases methylation differences in cardiomyocytes and non-cardiomyocytes were strain-dependent, confirming a strong genetic component for cytosine methylation. We observed preferential nucleotide usage associated with increased and decreased methylation that is remarkably conserved across species, suggesting a common mechanism for germline control of inter-individual variation in CpG methylation. In the RI strain panel, we found significant correlation of CpG methylation and levels of serum chromogranin B (CgB), a proposed biomarker of heart failure, which is evidence for a link between germline DNA sequence variation, CpG methylation differences and pathophysiological phenotypes in the SHR strain. Together, these results will stimulate further investigation of the molecular basis of locally regulated variation in CpG methylation and provide a starting point for understanding the relationship between the genetic control of CpG methylation and disease phenotypes.
publisher Public Library of Science
publishDate 2014
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4256262/
_version_ 1613164128680017920